sur NeoPrediX
NeoPrediX Secures Investment From Springhood Ventures
FORT LAUDERDALE, FL / ACCESSWIRE / September 10, 2024 / NeoPrediX, a company specializing in predictive analytics for neonatal, maternal, and perinatal health, has received an investment from Springhood Ventures. This capital will expedite the development of NeoPrediX's solutions aimed at improving newborn outcomes globally.
Springhood Ventures focuses exclusively on children's health, investing in early-stage companies with strong commercial potential in the health sector. Their partnership with NeoPrediX underscores their dedication to advancing neonatal care and assisting startups from inception to impactful solutions.
Thorsten Waloschek, CEO of NeoPrediX, stated that this investment validates their approach and will help scale their efforts quicker. John Parker, Founder of Springhood Ventures, expressed enthusiasm for supporting NeoPrediX in expanding their portfolio, emphasizing the potential to transform children's health.
This collaboration marks a pivotal moment for both entities as they work towards delivering groundbreaking, evidence-based technology to improve neonatal health worldwide.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NeoPrediX